Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-00193-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849728417771028480 |
|---|---|
| author | Mohammad-Reza Nejadmoghaddam Amir-Hassan Zarnani Ramin Ghahremanzadeh Roya Ghods Jafar Mahmoudian Maryam Yousefi Mahboobeh Nazari Mohammad Hossein Ghahremani Maryam Abolhasani Ali Anissian Morteza Mahmoudi Rassoul Dinarvand |
| author_facet | Mohammad-Reza Nejadmoghaddam Amir-Hassan Zarnani Ramin Ghahremanzadeh Roya Ghods Jafar Mahmoudian Maryam Yousefi Mahboobeh Nazari Mohammad Hossein Ghahremani Maryam Abolhasani Ali Anissian Morteza Mahmoudi Rassoul Dinarvand |
| author_sort | Mohammad-Reza Nejadmoghaddam |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b79c3777ae0e4eb29c8b3aea88626352 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-b79c3777ae0e4eb29c8b3aea886263522025-08-20T03:09:34ZengNature PortfolioScientific Reports2045-23222025-05-011511310.1038/s41598-025-00193-1Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapyMohammad-Reza Nejadmoghaddam0Amir-Hassan Zarnani1Ramin Ghahremanzadeh2Roya Ghods3Jafar Mahmoudian4Maryam Yousefi5Mahboobeh Nazari6Mohammad Hossein Ghahremani7Maryam Abolhasani8Ali Anissian9Morteza Mahmoudi10Rassoul Dinarvand11Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS)Reproductive Immunology Research Center, Avicenna Research Institute, ACECRNanobiotechnology Research Center, Avicenna Research Institute, ACECROncopathology Research Center, Iran University of Medical Sciences, IUMSNanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS)Nanobiotechnology Research Center, Avicenna Research Institute, ACECRMonoclonal Antibody Research Center, Avicenna Research Institute, ACECRNanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS)Department of Pathology, Hasheminejad Kidney Center, Iran University of Medical Sciences, IUMSVeterinary Department, Islamic Azad UniversityNanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS)Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS)https://doi.org/10.1038/s41598-025-00193-1 |
| spellingShingle | Mohammad-Reza Nejadmoghaddam Amir-Hassan Zarnani Ramin Ghahremanzadeh Roya Ghods Jafar Mahmoudian Maryam Yousefi Mahboobeh Nazari Mohammad Hossein Ghahremani Maryam Abolhasani Ali Anissian Morteza Mahmoudi Rassoul Dinarvand Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy Scientific Reports |
| title | Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy |
| title_full | Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy |
| title_fullStr | Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy |
| title_full_unstemmed | Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy |
| title_short | Author Correction: Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy |
| title_sort | author correction placenta specific1 plac1 is a potential target for antibody drug conjugate based prostate cancer immunotherapy |
| url | https://doi.org/10.1038/s41598-025-00193-1 |
| work_keys_str_mv | AT mohammadrezanejadmoghaddam authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT amirhassanzarnani authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT raminghahremanzadeh authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT royaghods authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT jafarmahmoudian authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT maryamyousefi authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT mahboobehnazari authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT mohammadhosseinghahremani authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT maryamabolhasani authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT alianissian authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT mortezamahmoudi authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy AT rassouldinarvand authorcorrectionplacentaspecific1plac1isapotentialtargetforantibodydrugconjugatebasedprostatecancerimmunotherapy |